News

16 May World Congress on Interventional Oncology to Present Live TheraSphere® Administration

Interventional Oncology Team at Northwestern Memorial Hospital to perform hepatocellular carcinoma liver-directed treatment with live narration

OTTAWA, Ontario–(BUSINESS WIRE)–May. 16, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced that for the second consecutive year, organizers of the World Congress on Interventional Oncology (WCIO) 2013 will host a live administration of TheraSphere^®, Nordion’s Yttrium-90 (Y-90) glass microspheres for the treatment of hepatocellular carcinoma (HCC)…

15 May Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals

OTTAWA, Ontario–(BUSINESS WIRE)–May. 15, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it has signed a contract manufacturing agreement with Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals…

10 Apr Nordion to Host Interactive TheraSphere(R) Educational Session at the SIR Annual Scientific Meeting 2013

Session to complement Nordion’s educational portfolio for physicians

OTTAWA, Ontario–(BUSINESS WIRE)–Apr. 10, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host an educational session called “TheraSphere® Test Flight Interactive: How to Treat or Should I Treat?” at the Society for Interventional Radiologists (SIR) Annual Scientific Meeting, taking place April 13-18 in New Orleans, Louisiana…

09 Apr Nordion to Host European-Based Educational and Scientific Meetings for Liver Cancer Specialists

Meetings designed to support TheraSphere® treatment growth and expansion in Europe

OTTAWA, Ontario–(BUSINESS WIRE)–Apr. 9, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, will host two upcoming educational and scientific meetings to support the growth and expansion of TheraSphere® treatment in Europe…

05 Mar Nordion Launches a New and Improved TheraSphere(R) Website to Meet the Needs of Liver Cancer Physicians, Patients and Caregivers Worldwide

TheraSphere.com provides unique resources and targeted information about this innovative radioembolization therapy

OTTAWA, Ontario–(BUSINESS WIRE)–Mar. 5, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today that it has launched a new and improved, intuitive, feature-rich TheraSphere® website, providing liver cancer patients and physicians with customized TheraSphere® resources that include medical and clinical information, convenient online ordering, and innovative digital resources…

28 Jan Nordion Appoints Mr. Grant Gardiner as SVP and General Counsel

OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 28, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it is appointing Grant Gardiner as Senior Vice President, General Counsel & Corporate Secretary. Mr. Gardiner will serve as the Corporation’s legal officer responsible for all global legal matters, effective March 18, 2013…

24 Jan Nordion, Manufacturer of TheraSphere(R), to Host Educational Symposium at the 2013 Gastrointestinal Cancers Symposium

Agenda includes new HCC clinical data and an update on TheraSphere® Phase III clinical trials OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 24, 2013– Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today it is hosting…